Skip to main content

Table 1 Patient characteristics (N = 70)a

From: The Carpentier-Edwards Perimount Magna mitral valve bioprosthesis: intermediate-term efficacy and durability

Demographics

 

 Age, years

68 ± 1.6

 Gender

 

  Men

36 (51 %)

  Women

34 (49 %)

Preoperative clinical and laboratory values

 

 BMI,b kg/m2

26.5 ± 0.7

 Hematocrit, %

35.8 ± 0.7

 Creatinine (mg/dl)

1.6 ± 0.2

Disease acuteness

 

 NYHA functional class

 

  I or II

40 (57 %)

  III or IV

30 (43 %)

 Emergency operation

 

  Yes

3 (4.3 %)

  No

67 (96 %)

 IABP use

 

  Yes

3 (4.3 %)

  No

67 (96 %)

Cardiac comorbidities

 

 Coronary artery disease

21 (30 %)

 EF, %

55 ± 1.2

 Moderately severe, or worse, MR

36 (51 %)

 Severe MS

21 (30 %)

 History of heart failure

 

  Yes

22 (31 %)

  No

48 (69 %)

 Previous MI

 

  Yes

10 (14 %)

  No

60 (86 %)

 Preoperative cardiogenic shock

9 (13 %)

  Yes

  No

61 (87 %)

 History of peripheral artery disease

 

  Yes

4 (5.7 %)

  No

66 (94 %)

 Previous cardiac operation

 

  Yes

30 (43 %)

  No

40 (57 %)

 Previous mitral valve repair or replacement

 

  Yes

19 (27 %)

  No

51 (73 %)

 Preoperative AF

 

  Yes

19 (27 %)

  No

51 (73 %)

 History of hypertension

 

  Yes

53 (76 %)

  No

17 (24 %)

Noncardiac comorbidities

 

 Previous stroke

 

  Yes

8 (11 %)

  No

62 (89 %)

 History of carotid artery diseaseb

 

  Yes

26 (37 %)

  No

43 (61 %)

 History of smoking

 

  Yes

29 (41 %)

  No

41 (59 %)

 History of COPD

 

  Yes

11 (16 %)

  No

59 (84 %)

 History of DM

 

  Yes

17 (24 %)

  No

53 (76 %)

 History of renal disease

 

  Yes

20 (29 %)

  No

50 (71 %)

  1. BMI body mass index, NYHA New York Heart Association, IABP intraaortic balloon pump, EF ejection fraction, AF atrial fibrillation, MI myocardial infarction, COPD chronic obstructive pulmonary disease, DM diabetes mellitus, MR mitral regurgitation, MS mitral stenosis
  2. aContinuous variables expressed as mean ± standard error of the mean (SE); categorical variables, as n (percentage)
  3. bData available for only 69 patients